References
- Muchowski JM, Unger SH, Ackrell J, Cheung P, Cooper GF, Cook J et al. (1985). Synthesis and anti-inflammatory and analgesic activity of 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and related compounds. J Med Chem, 28:1037–1049.
- Radi ZA, Khan NK. (2006). Effects of cyclooxygenase inhibition on the gastrointestinal tract. Exp Toxicol Pathol, 58:163–173.
- Gilroy DW, Tomlinson A, Willoughby DA. (1998). Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation. Eur J Pharmacol, 355:211–217.
- Laine L. (2003). Gastrointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage, 25:32–40.
- Menozzi A, Pozzoli C, Giovannini E, Solenghi E, Grandi D, Bonardi S et al. (2006). Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat. Eur J Pharmacol, 552:143–150.
- Doh HJ, Cho WJ, Yong CS, Choi HG, Kim JS, Lee CH et al. (2003). Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery. J Pharm Sci, 92:1008–1017.
- Kim BY, Doh HJ, Le TN, Cho WJ, Yong CS, Choi HG et al. (2005). Ketorolac amide prodrugs for transdermal delivery: stability and in vitro rat skin permeation studies. Int J Pharm, 293:193–202.
- Puglia C, Filosa R, Peduto A, de Caprariis P, Rizza L, Bonina F et al. (2006). Evaluation of alternative strategies to optimize ketorolac transdermal delivery. AAPS PharmSciTech, 7:64.
- Bhandari KH, Newa M, Yoon SI, Kim JS, Jang KY, Kim JA et al. (2007). Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs. Biol Pharm Bull, 30:2211–2216.
- Bhandari KH, Newa M, Yoon SI, Kim JS, Kim DD, Kim JA et al. (2007). Evaluation of skin permeation and accumulation profiles of ketorolac fatty esters. J Pharm Pharm Sci, 10:278–287.
- Mishra A, Veerasamy R, Jain PK, Dixit VK, Agrawal RK. (2008). Synthesis, characterization and pharmacological evaluation of amide prodrugs of ketorolac. Eur J Med Chem, 43:2464–2472.
- Qandil A, Al-Nabulsi S, Al-Taani B, Tashtoush B. (2008). Synthesis of piperazinylalkyl ester prodrugs of ketorolac and their in vitro evaluation for transdermal delivery. Drug Dev Ind Pharm, 34:1054–1063.
- Al-Tirawi AM. (2010). Evaluation of oral bioavailabity and toxicity of piperazinylalkyl esters of ketorolac in animals. Irbid, Jordan: Jordan University of Science and Technology.
- Tammara VK, Narurkar MM, Crider AM, Khan MA. (1993). Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen. Pharm Res, 10:1191–1199.
- Rautio J, Nevalainen T, Taipale H, Vepsäläinen J, Gynther J, Laine K et al. (2000). Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation. Eur J Pharm Sci, 11:157–163.
- Yadav M, Halen P, Chagti K, Hemalatha B, Giridhar R. (2005). A novel approach towards therapeutic optimization of diclofenac. Ars Pharm 46: 263–277.
- Halen P, Yadav M, Chagti K, Reshmi C, Giridhar R. (2006). Synthesis and evaluation of dual acting esters of aspirin and ketorolac. Ars Pharm 47:61–79.
- Halen PK, Chagti KK, Giridhar R, Yadav MR. (2007). Combining anticholinergic and anti-inflammatory activities into a single moiety: a novel approach to reduce gastrointestinal toxicity of ibuprofen and ketoprofen. Chem Biol Drug Des, 70:450–455.
- Halen P, Chagti K, Giridhar R, Yadav M. (2007). Substituted aminoalcohol ester analogs of indomethacin with reduced toxic effects. Med Chem Res 16:101–111.
- Connors K, Amidon G, Stella V. (1986). Chemical stability of pharmaceuticals: a handbook for pharmacists (Second Edition). Hoboken, NJ, USA: John Wiley & Sons, Inc.
- Dewar MJS, Dieter KM. (1986). Evaluation of AM1 calculated proton affinities and deprotonation enthalpies. J Am Chem Soc, 108:8075–8086.
- Wang Z, Dsida RM, Avram MJ. (2001). Determination of ketorolac in human plasma by reversed-phase high-performance liquid chromatography using solid-phase extraction and ultraviolet detection. J Chromatogr B Biomed Sci Appl, 755:383–386.
- Loudon GM. (1991). Mechanistic interpretation of pH-rate profiles. J Chem Educ, 68:973.
- Qandil A, Tashtoush B, Al-Taani B, Al-Nabulsi S, Al-Zogoul F. (2008) Simultaneous RP-LC determination of ketorolac and its piperazinylalkyl ester prodrugs. Chromatographia, 67:287–291.